TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT04893915

Cytokine-induced Memory-like NK Cells in Relapsed/Refractory AML and MDS

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.
“No funding support”

The sponsor’s own words in the registry.

Life of this trial

202120222023Registered2021-05-14Withdrawn (as of)2022-03-11Planned start2022-06-30 (planned)

Vital statistics

Status
Withdrawn
Phase
Phase 2
Sponsor
Washington University School of Medicine
Sponsor type
University, hospital or other
Conditions
Relapsed Acute Myeloid Leukemia; Refractory Acute Myeloid Leukemia; Myelodysplastic Syndromes
Interventions
Cytokine-induced memory-like NK cells; Fludarabine; Cyclophosphamide; Donor Leukapheresis; Interleukin-2
Participants
0

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.